OnKure Therapeutics, Inc. (OKUR) has 17 open-market insider trades by 5 insiders since 2025. Over the last six months insiders net sold $3K. The most active filer is Jason A. Leverone, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Cormorant Private Healthcare Fund III LP | — | — | 1 | $6.7M | 2025-05-15 |
| ACORN Capital Advisors Gp, LLC | 10% Owner | — | 1 | $5.2M | 2025-05-15 |
| Cormorant Global Healthcare Master Fund, LP | 10% | — | 1 | $48K | 2025-05-12 |
| Jason A. Leverone | CFO | — | 7 | $16K | 2026-09-21 |
| Nicholas A. Saccomano | CEOPres | — | 7 | $5K | 2026-09-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Nicholas A. Saccomano | CEO & President | Sell | $259 | 2026-09-21 |
| Jason A. Leverone | CFO | Sell | $898 | 2026-09-21 |
| Nicholas A. Saccomano | CEO & President | Sell | $378 | 2026-06-22 |
| Jason A. Leverone | CFO | Sell | $1K | 2026-06-22 |
| Jason A. Leverone | CFO | Sell | $3K | 2026-03-23 |
| Nicholas A. Saccomano | CEO & President | Sell | $715 |
Companies that share insiders with OKUR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-03-23 |
| Jason A. Leverone | CFO | Sell | $897 | 2025-12-22 |
| Nicholas A. Saccomano | President | Sell | $258 | 2025-12-22 |
| Jason A. Leverone | CFO | Sell | $794 | 2025-09-22 |
| Nicholas A. Saccomano | President | Sell | $231 | 2025-09-22 |
| Jason A. Leverone | CFO | Sell | $721 | 2025-06-23 |
| Nicholas A. Saccomano | President | Sell | $209 | 2025-06-23 |
| ACORN Capital Advisors Gp, LLC | 10% Owner | Buy | $5.2M | 2025-05-15 |
| Cormorant Private Healthcare Fund III LP | — | Sell | $6.7M | 2025-05-15 |
| Cormorant Global Healthcare Master Fund, LP | 10% | Sell | $48K | 2025-05-12 |